Paris (ots/PRNewswire) – Sanofi-aventis announced today that results from the RealiseAF (Real-life global survey evaluating patients with Atrial Fibrillation) registry show that control of atrial fibrillation (AF) (defined by the 2006 ACC/AHA/ESC AF guidelines as either sinus rhythm or AF with heart rate at rest less than or equal 80 bpm)[1] was not achieved in [...]
Tag Archive > Coronary Intervention
New Analysis Showed Efient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Tokyo and Indianapolis (ots/PRNewswire) – Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Efient(R) (prasugrel) compared with branded clopidogrel (Plavix(R)) was more cost effective, and in most cases cost saving. These results [...]
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Paris, and Princeton, New Jersey (ots/PRNewswire) – -No added benefit on the composite primary end-point with the higher dose when entire ACS study population considered- -Important new findings with higher loading dose of PLAVIX(R) for heart patients undergoing coronary angioplasty (PCI)- Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical [...]
